September 2026
Trump slams Iran and Cuba, boasts about record in United Nations speech
The U.S. “will no longer permit threats to America to gain a foothold anywhere in the Western Hemisphere,” Trump told the UN leaders.
McDonald’s is hosting an investor day as its U.S. business struggles. Here are 4 things to expect
The presentation comes as McDonald’s U.S. business disappointed in its most recent quarter.
Democrats lead the polls. Republicans lead in cash heading into the midterms
Republicans hold a $103 million cash advantage across national party committees as the fight for control of Congress enters its final six weeks.
Hundreds of flights into Newark, New York, Philadelphia disrupted after Verizon fiber line cut
An FAA equipment problem snarled air travel at Newark Liberty International Airport and Philadelphia International Airport Monday.
Trump to press Zelenskyy for energy truce, says Russia has ‘lost control’ of oil due to Ukraine war
U.S. President Donald Trump said Russia has “lost control” of its diesel oil industry due to the Ukraine war, as he presses Kyiv to agree to an energy truce.
Paramount and state AGs settle lawsuit, allowing Warner Bros. merger to proceed
The antitrust lawsuit threatened to delay Paramount’s acquisition until mid-2027 and to cost the company hundreds of millions of dollars in fees.
All Iranian airlines to be ‘shut down’ from Wednesday, Bessent tells CNBC
The Treasury Secretary said that Washington was pressuring Iran “like never before”
Eli Lilly CEO says 700,000 new seniors have started GLP-1s after Medicare coverage, and 70% are on Lilly drugs
They’re the latest metrics on how much the new Medicare coverage is expanding access to GLP-1 medicines since it launched in July.
Trump, Xi seek trade stability and deals, but AI, tariffs and Iran loom large. What to watch
Trump, facing low approval on the economy ahead of the midterm election, has an added incentive to emerge from the summit with China’s Xi touting trade wins.
Eli Lilly CEO tells CNBC one-third of new GLP-1 pill patients are taking Foundayo, as drugmaker ramps up production
Eli Lilly is trying to catch up in the GLP-1 pill market to Novo, which got a head start in the space.